Clinical Trial Update: Role of Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) on Inflammation and Lipids [NA]

View source ↗

Summary

Clinical trial update examining the role of EPA and DHA on inflammation and lipids in metabolic syndrome; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome

Drugs mentioned

• Docosahexaenoic acid (docosahexaenoic acid)
• Eicosapentaenoic acid (eicosapentaenoic acid)

Snippet

Sponsor: Tufts University | Conditions: Metabolic Syndrome | NA | Status: COMPLETED | Results posted: 2021-04-14